Novavax
NVAX
#5087
Rank
โ‚ฌ1.61 B
Marketcap
9,76ย โ‚ฌ
Share price
1.39%
Change (1 day)
58.63%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2023 (TTM): -6,87ย โ‚ฌ

According to Novavax's latest financial reports the company's current EPS (TTM) is -1,36ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -7,41ย โ‚ฌ an increase over its 2021 EPS that were of -20,80ย โ‚ฌ.

EPS history for Novavax from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-6,87ย โ‚ฌ-7.35%
2022-7,41ย โ‚ฌ-64.36%
2021-20,80ย โ‚ฌ243%
2020-6,06ย โ‚ฌ19.75%
2019-5,06ย โ‚ฌ-43.86%
2018-9,02ย โ‚ฌ-19.84%
2017-11,25ย โ‚ฌ-38.83%
2016-18,39ย โ‚ฌ74.58%
2015-10,54ย โ‚ฌ63.89%
2014-6,43ย โ‚ฌ16.13%
2013-5,54ย โ‚ฌ40.91%
2012-3,93ย โ‚ฌ29.41%
2011-3,04ย โ‚ฌ-50%
2010-6,07ย โ‚ฌ-27.66%
2009-8,39ย โ‚ฌ-11.32%
2008-9,46ย โ‚ฌ-7.02%
2007-10,18ย โ‚ฌ46.15%
2006-6,96ย โ‚ฌ50%
2005-4,64ย โ‚ฌ-63.38%
2004-12,68ย โ‚ฌ20.34%
2003-10,54ย โ‚ฌ-35.87%
2002-16,43ย โ‚ฌ113.95%
2001-7,68ย โ‚ฌ-33.85%
2000-11,61ย โ‚ฌ122.17%
1999-5,22ย โ‚ฌ-40.38%
1998-8,76ย โ‚ฌ30%
1997-6,74ย โ‚ฌ-9.007199254741E+17%
19960,0000000000ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,69ย โ‚ฌ-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,68ย โ‚ฌ-150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5,96ย โ‚ฌ-539.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2,57ย โ‚ฌ-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,35ย โ‚ฌ 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,88ย โ‚ฌ 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,80ย โ‚ฌ-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-0,39ย โ‚ฌ-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,29ย โ‚ฌ-5.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-3,07ย โ‚ฌ 126.32%๐Ÿ‡บ๐Ÿ‡ธ USA